Cargando…

Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)

The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (SUNN) study was a population-based screening study that aimed to provide proof of concept to encourage community-level screening and detection for this non-communicable disease. Current screening guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskridge, Wayne, Vierling, John M., Gosbee, Wayne, Wan, Gabriella A., Hyunh, May-Linh, Chang, Henry E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631660/
https://www.ncbi.nlm.nih.gov/pubmed/34847156
http://dx.doi.org/10.1371/journal.pone.0260320
_version_ 1784607607194910720
author Eskridge, Wayne
Vierling, John M.
Gosbee, Wayne
Wan, Gabriella A.
Hyunh, May-Linh
Chang, Henry E.
author_facet Eskridge, Wayne
Vierling, John M.
Gosbee, Wayne
Wan, Gabriella A.
Hyunh, May-Linh
Chang, Henry E.
author_sort Eskridge, Wayne
collection PubMed
description The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (SUNN) study was a population-based screening study that aimed to provide proof of concept to encourage community-level screening and detection for this non-communicable disease. Current screening guidelines do not recommend the routine screening of nonalcoholic fatty liver disease (NAFLD) for asymptomatic populations, so providers are not encouraged to actively seek disease, even in high-risk patients. This study sought to determine whether a self-selecting cohort of asymptomatic individuals would have scores based on vibration controlled transient elastography (VCTE) and controlled attenuation parameter (CAP) significantly correlated to risk factors to suggest that routine screening for high-risk patients should be recommended. The study recruited 1,070 self-selected participants in Houston and Galveston County, Texas, 940 of which were included in final analysis. A pre-screening survey was used to determine eligibility. VCTE-based scores analyzed steatosis and fibrosis levels. Fifty-seven percent of the study population demonstrated steatosis without fibrosis, suggesting NAFLD, while 16% demonstrated both steatosis and fibrosis, suggesting NASH. Statistically significant risk factors included factors related to metabolic syndrome, race, and age, while statistically significant protective factors included consumption of certain foods and exercise. The findings of this study suggest that high-risk individuals should be screened for NAFLD even in the absence of symptoms and that community-based screenings are an effective tool, particularly in the absence of proactive guidelines for providers.
format Online
Article
Text
id pubmed-8631660
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-86316602021-12-01 Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE) Eskridge, Wayne Vierling, John M. Gosbee, Wayne Wan, Gabriella A. Hyunh, May-Linh Chang, Henry E. PLoS One Research Article The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (SUNN) study was a population-based screening study that aimed to provide proof of concept to encourage community-level screening and detection for this non-communicable disease. Current screening guidelines do not recommend the routine screening of nonalcoholic fatty liver disease (NAFLD) for asymptomatic populations, so providers are not encouraged to actively seek disease, even in high-risk patients. This study sought to determine whether a self-selecting cohort of asymptomatic individuals would have scores based on vibration controlled transient elastography (VCTE) and controlled attenuation parameter (CAP) significantly correlated to risk factors to suggest that routine screening for high-risk patients should be recommended. The study recruited 1,070 self-selected participants in Houston and Galveston County, Texas, 940 of which were included in final analysis. A pre-screening survey was used to determine eligibility. VCTE-based scores analyzed steatosis and fibrosis levels. Fifty-seven percent of the study population demonstrated steatosis without fibrosis, suggesting NAFLD, while 16% demonstrated both steatosis and fibrosis, suggesting NASH. Statistically significant risk factors included factors related to metabolic syndrome, race, and age, while statistically significant protective factors included consumption of certain foods and exercise. The findings of this study suggest that high-risk individuals should be screened for NAFLD even in the absence of symptoms and that community-based screenings are an effective tool, particularly in the absence of proactive guidelines for providers. Public Library of Science 2021-11-30 /pmc/articles/PMC8631660/ /pubmed/34847156 http://dx.doi.org/10.1371/journal.pone.0260320 Text en © 2021 Eskridge et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Eskridge, Wayne
Vierling, John M.
Gosbee, Wayne
Wan, Gabriella A.
Hyunh, May-Linh
Chang, Henry E.
Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
title Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
title_full Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
title_fullStr Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
title_full_unstemmed Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
title_short Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
title_sort screening for undiagnosed non-alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis (nash): a population-based risk factor assessment using vibration controlled transient elastography (vcte)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631660/
https://www.ncbi.nlm.nih.gov/pubmed/34847156
http://dx.doi.org/10.1371/journal.pone.0260320
work_keys_str_mv AT eskridgewayne screeningforundiagnosednonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashapopulationbasedriskfactorassessmentusingvibrationcontrolledtransientelastographyvcte
AT vierlingjohnm screeningforundiagnosednonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashapopulationbasedriskfactorassessmentusingvibrationcontrolledtransientelastographyvcte
AT gosbeewayne screeningforundiagnosednonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashapopulationbasedriskfactorassessmentusingvibrationcontrolledtransientelastographyvcte
AT wangabriellaa screeningforundiagnosednonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashapopulationbasedriskfactorassessmentusingvibrationcontrolledtransientelastographyvcte
AT hyunhmaylinh screeningforundiagnosednonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashapopulationbasedriskfactorassessmentusingvibrationcontrolledtransientelastographyvcte
AT changhenrye screeningforundiagnosednonalcoholicfattyliverdiseasenafldandnonalcoholicsteatohepatitisnashapopulationbasedriskfactorassessmentusingvibrationcontrolledtransientelastographyvcte